WebAug 15, 2024 · Acute promyelocytic leukemia (APL) has become a highly curable disease. 1-4 All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) are the backbone of modern treatments for APL and have led to complete remission (CR) in 90% to 100% of patients in clinical trials and an overall survival (OS) between 86% and 97%. 5-15 The practice … WebMay 5, 2024 · Chemotherapy combined with other treatments may be one of the ways to solve chemotherapy resistance of HCC. 15,17,18 All-trans retinoic acid (ATRA), a key metabolite of vitamin A, is regarded as the first effective targeted therapy for acute promyelocytic leukemia (APL), and its effects have rarely been reported in solid cancers. …
How we prevent and treat differentiation syndrome in patients …
WebUpdated results from the APL0406 study suggest that the combination of all-trans retinoic acid (ATRA) plus arsenic trioxide (ATO) was associated with greater long-term event-free survival (EFS) and disease-free survival (DFS) in patients with low- and intermediate-risk acute promyelocytic leukemia (APL), compared with ATRA plus chemotherapy (ATRA … WebFeb 23, 2016 · The investigators propose a modified ATO/ATRA protocol with the addition of two doses of IDA (50% compared to standard AIDA induction) for induction because of the anticipated need of adding anthracyclines to control hyperleukocytosis and to achieve long-term disease control in this high-risk APL population. for new phone deals
Chemotherapy-Free Regimen of ATRA Plus Arsenic Trioxide Improves
WebApr 1, 2024 · In spite of the recent improvement in the outcome of acute promyelocytic leukaemia (APL) with treatment combining all trans retinoic acid (ATRA) and chemotherapy (CT), some patients with this disease still have a poor outcome. The prognostic significance of chromosomal abnormalities in addition to t(15;17) in APL is … WebMar 24, 2009 · Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia (DECIDER) ... VPA or another HDAC inhibitor, or ATRA; "Low-dose" chemotherapy (e.g. hydroxyurea, cytosine arabinoside (Ara-C), melphalan, clofarabine etc.) within 4 weeks prior to DAC treatment, except for … WebAcute promyelocytic leukemia (APL) is treated differently than other forms of acute myeloid leukemia. Many people with APL are first treated with a drug called all-trans-retinoic … dight light saving time